Tucson, AZ, February 5th 2024 — SynCardia Systems, LLC., a Picard Medical Company, proudly announces that the U.S. Patent and Trademark Office (USPTO) has allowed claims of its groundbreaking patent application “Next Generation Total Artificial Heart” covering next generation total artificial heart designs.
The application describes novel technology aimed at eliminating external drive mechanisms by fully integrating the pumping mechanism within the implanted artificial heart ventricle. This new design represents a significant leap forward towards achieving a fully implantable system.Continue reading